Glutamate clearance mechanisms in resected cortical dysplasia: Laboratory investigation

Journal of Neurosurgery

Volumn 114, Issue 4, 2011, Pages 1195-1202

  González Martínez, Jorge A ^a   Ying, Zhong ^a   Prayson, Richard ^a   Bingaman, William ^a   Najm, Imad ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Balloon cell; Glia; Glutamate transporter; Glutamine synthetase; Malformations of cortical development

Indexed keywords

EAAC1 PROTEIN; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; GLUTAMATE TRANSPORTER; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1;

ADOLESCENT; ADULT; AMINO ACID METABOLISM; ARTICLE; BRAIN TISSUE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL DYSPLASIA; ELECTROCORTICOGRAPHY; EPILEPTIC DISCHARGE; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; GLIA; GLUTAMATE CLEARANCE; GRAND MAL EPILEPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACTABLE EPILEPSY; MALE; NERVE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; ADULT; AMINO ACID TRANSPORT SYSTEM X-AG; CHILD; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMATE-AMMONIA LIGASE; GLUTAMIC ACID; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT; MONITORING, INTRAOPERATIVE; NEOCORTEX; NEUROGLIA; NEURONS; NEUROSURGICAL PROCEDURES; YOUNG ADULT;

EID: 79953695981     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.10.JNS10715     Document Type: Article

References (41)

1. Anderson CM, Swanson RA: Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32:1-14, 2000
2. Bautista JF, Foldvary-Schaefer N, Bingaman WE, Lüders HO: Focal cortical dysplasia and intractable epilepsy in adults: clinical, EEG, imaging, and surgical features. Epilepsy Res 55:131-136, 2003 (Pubitemid 37011377)
3. Binder DK, Steinhäuser C: Functional changes in astroglial cells in epilepsy. Glia 54:358-368, 2006 (Pubitemid 44422938)
4. Bjørnsen LP, Eid T, Holmseth S, Danbolt NC, Spencer DD, de Lanerolle NC: Changes in glial glutamate transporters in human epileptogenic hippocampus: inadequate explanation for high extracellular glutamate during seizures. Neurobiol Dis 25:319-330, 2007 (Pubitemid 46124012)
5. Boonyapisit K, Najm I, Klem G, Ying Z, Burrier C, LaPresto E, et al: Epileptogenicity of focal malformations due to abnormal cortical development: direct electrocorticographichistopathologic correlations. Epilepsia 44:69-76, 2003 (Pubitemid 36733623)
6. Campbell SL, Hablitz JJ: Decreased glutamate transport enhances excitability in a rat model of cortical dysplasia. Neurobiol Dis 32:254-261, 2008
7. Carl GF, Blackwell LK, Barnett FC, Thompson LA, Rissinger CJ, Olin KL, et al: Manganese and epilepsy: brain glutamine synthetase and liver arginase activities in genetically epilepsy prone and chronically seizured rats. Epilepsia 34:441-446, 1993 (Pubitemid 23184578)
8. Claudio OI, Ferchmin P, Velísek L, Sperber EF, Moshé SL, Ortiz JG: Plasticity of excitatory amino acid transporters in experimental epilepsy. Epilepsia 41 (Suppl 6):S104-S110, 2000
9. Domercq M, Matute C: Expression of glutamate transporters in the adult bovine corpus callosum. Brain Res Mol Brain Res 67:296-302, 1999 (Pubitemid 29193186)
10. Dutuit M, Didier-Bazès M, Vergnes M, Mutin M, Conjard A, Akaoka H, et al: Specific alteration in the expression of glial fibrillary acidic protein, glutamate dehydrogenase, and glutamine synthetase in rats with genetic absence epilepsy. Glia 32:15-24, 2000
11. Furuta A, Rothstein JD, Martin LJ: Glutamate transporter protein subtypes are expressed differentially during rat CNS development. J Neurosci 17:8363-8375, 1997 (Pubitemid 27461059)
12. González-Martínez JA, Bingaman WE, Toms SA, Najm IM: Neurogenesis in the postnatal human epileptic brain. J Neurosurg 107:628-635, 2007 (Pubitemid 47451048)
13. Harrington EP, Möddel G, Najm IM, Baraban SC: Altered glutamate receptor-transporter expression and spontaneous seizures in rats exposed to methylazoxymethanol in utero. Epilepsia 48:158-168, 2007 (Pubitemid 46096038)
14. Ingram EM, Tessler S, Bowery NG, Emson PC: Glial glutamate transporter mRNAs in the genetically absence epilepsy rat from Strasbourg. Brain Res Mol Brain Res 75:96-104, 2000 (Pubitemid 30058330)
15. Jeha LE, Najm IM, Bingaman WE, Khandwala F, Widdess- Walsh P, Morris HH, et al: Predictors of outcome after temporal lobectomy for the treatment of intractable epilepsy. Neurology 66:1938-1940, 2006
16. Kawashima T, Adachi T, Tokunaga Y, Furuta A, Suzuki SO, Doh-ura K, et al: Immunohistochemical analysis in a case of idiopathic Lennox-Gastaut syndrome. Clin Neuropathol 18: 286-292, 1999 (Pubitemid 29526252)
17. Kondo K, Hashimoto H, Kitanaka J, Sawada M, Suzumura A, Marunouchi T, et al: Expression of glutamate transporters in cultured glial cells. Neurosci Lett 188:140-142, 1995
18. Laming PR, Cosby SL, O'Neill JK: Seizures in the Mongolian gerbil are related to a deficiency in cerebral glutamine synthetase. Comp Biochem Physiol C 94:399-404, 1989 (Pubitemid 20107521)
19. Lamparello P, Baybis M, Pollard J, Hol EM, Eisenstat DD, Aronica E, et al: Developmental lineage of cell types in cortical dysplasia with balloon cells. Brain 130:2267-2276, 2007 (Pubitemid 47327637)
20. Lüders H, Schuele SU: Epilepsy surgery in patients with malformations of cortical development. Curr Opin Neurol 19: 169-174, 2006
21. Mathern GW, Mendoza D, Lozada A, Pretorius JK, Dehnes Y, Danbolt NC, et al: Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology 52:453-472, 1999 (Pubitemid 29075589)
22. Milh M, Becq H, Villeneuve N, Ben-Ari Y, Aniksztejn L: Inhibition of glutamate transporters results in a "suppressionburst" pattern and partial seizures in the newborn rat. Epilepsia 48:169-174, 2007
23. Mischel PS, Nguyen LP, Vinters HV: Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 54:137-153, 1995
24. Najm IM, Bingaman WE, Lüders HO: The use of subdural grids in the management of focal malformations due to abnormal cortical development. Neurosurg Clin N Am 13:87-92, viii-ix, 2002
25. Najm IM, Tilelli CQ, Oghlakian R: Pathophysiological mechanisms of focal cortical dysplasia: a critical review of human tissue studies and animal models. Epilepsia 48 (Suppl 2):21-32, 2007 (Pubitemid 46850000)
26. Najm IM, Ying Z, Babb T, Mohamed A, Hadam J, LaPresto E, et al: Epileptogenicity correlated with increased N-methyl- D-aspartate receptor subunit NR2A/B in human focal cortical dysplasia. Epilepsia 41:971-976, 2000 (Pubitemid 30640861)
27. Oh HS, Lee MC, Kim HS, Lee JS, Lee JH, Kim MK, et al: Pathophysiologic characteristics of balloon cells in cortical dysplasia. Childs Nerv Syst 24:175-183, 2008
28. O'Kane RL, Martínez-López I, DeJoseph MR, Viña JR, Hawkins RA: Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J Biol Chem 274:31891-31895, 1999
29. Palmini A, Najm I, Avanzini G, Babb T, Guerrini R, Foldvary-Schaefer N, et al: Terminology and classification of the cortical dysplasias. Neurology 62 (6 Suppl 3):S2-S8, 2004 (Pubitemid 38419835)
30. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, et al: Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675-686, 1996 (Pubitemid 26103145)
31. Rothstein JD, Martin L, Levey AI, Dykes-Hoberg M, Jin L, Wu D, et al: Localization of neuronal and glial glutamate transporters. Neuron 13:713-725, 1994 (Pubitemid 24300175)
32. Scimemi A, Schorge S, Kullmann DM, Walker MC: Epileptogenesis is associated with enhanced glutamatergic transmission in the perforant path. J Neurophysiol 95:1213-1220, 2006 (Pubitemid 44699117)
33. Stafstrom CE: The role of glutamate transporters in developmental epilepsy: a concept in flux. Epilepsy Curr 4:243-244, 2004
34. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, et al: Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276:1699-1702, 1997 (Pubitemid 27421977)
35. Tassi L, Colombo N, Garbelli R, Francione S, Lo Russo G, Mai R, et al: Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 125: 1719-1732, 2002
36. Tassi L, Pasquier B, Minotti L, Garbelli R, Kahane P, Benabid AL, et al: Cortical dysplasia: electroclinical, imaging, and neuropathologic study of 13 patients. Epilepsia 42:1112-1123, 2001 (Pubitemid 32947929)
37. Tiffany-Castiglioni EC, Peterson SL, Castiglioni AJ: Alterations in glutamine synthetase activity by FeCl2-induced focal and kindled amygdaloid seizures. J Neurosci Res 25:223-228, 1990 (Pubitemid 20093973)
38. Ueda Y, Willmore LJ: Sequential changes in glutamate transporter protein levels during Fe(3+)-induced epileptogenesis. Epilepsy Res 39:201-209, 2000 (Pubitemid 30193388)
39. van der Hel WS, Verlinde SA, Meijer DH, de Wit M, Rensen MG, van Gassen KL, et al: Hippocampal distribution of vesicular glutamate transporter 1 in patients with temporal lobe epilepsy. Epilepsia 50:1717-1728, 2009
40. Widdess-Walsh P, Jeha L, Nair D, Kotagal P, Bingaman W, Najm I: Subdural electrode analysis in focal cortical dysplasia: predictors of surgical outcome. Neurology 69:660-667, 2007 (Pubitemid 47256008)
41. Ying Z, Gonzalez-Martinez J, Tilelli C, Bingaman W, Najm I: Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia. Epilepsia 46: 1716-1723, 2005 (Pubitemid 44921956)